Symbols / CVS $70.14 +0.09% CVS Health Corporation

Healthcare • Healthcare Plans • United States • NYQ
CVS Chart
About

CVS Health Corporation provides health solutions in the United States. The company operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare Supplement plans, PDPS and Medicaid health care management services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail order pharmacy, clinical, disease management, medical spend management services, pharmacy and other administrative services. It serves employers, insurance companies, unions, government employee groups, health plans, PDPS, Medicaid managed care plans, CMS, plans offered on public health insurance, and other sponsors of health benefit plans. The Pharmacy & Consumer Wellness segment sells prescription and over-the-counter drugs, consumer health and beauty products, personal care products, and other general merchandise products. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. It operates online retail pharmacy websites, retail specialty pharmacy stores, compounding pharmacies and branches for infusion and enteral nutrition services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1963 and is headquartered in Woonsocket, Rhode Island.

Fundamentals
Scroll to Statements
Sector Healthcare Industry Healthcare Plans Market Cap 89.23B
Enterprise Value 158.75B Income 1.77B Sales 399.83B
Book/sh 59.18 Cash/sh 8.33 Dividend Yield 3.79%
Payout 191.37% Employees 219000 IPO —
P/E 50.46 Forward P/E 8.58 PEG —
P/S 0.22 P/B 1.19 P/C —
EV/EBITDA 10.86 EV/Sales 0.40 Quick Ratio 0.57
Current Ratio 0.84 Debt/Eq 106.06 LT Debt/Eq —
EPS (ttm) 1.39 EPS next Y 8.17 EPS Growth 76.60%
Revenue Growth 8.40% Earnings 2026-05-06 ROA 2.47%
ROE 2.29% ROIC — Gross Margin 13.29%
Oper. Margin 1.57% Profit Margin 0.44% Shs Outstand 1.27B
Shs Float 1.27B Short Float 1.42% Short Ratio 2.36
Short Interest — 52W High 85.15 52W Low 58.35
Beta 0.46 Avg Volume 8.67M Volume 4.71M
Target Price $96.50 Recom Strong_buy Prev Close $70.08
Price $70.14 Change 0.09%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$96.50
Mean price target
2. Current target
$70.14
Latest analyst target
3. DCF / Fair value
$83.89
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$70.14
Low
$79.00
High
$138.00
Mean
$96.50

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-03-12 up Bernstein Market Perform → Outperform $94
2026-01-28 main Argus Research Buy → Buy $90
2026-01-27 main B of A Securities Buy → Buy $95
2026-01-06 main Bernstein Market Perform → Market Perform $91
2025-12-17 main JP Morgan Overweight → Overweight $101
2025-12-12 main Bernstein Market Perform → Market Perform $87
2025-12-10 main Truist Securities Buy → Buy $98
2025-12-10 reit Piper Sandler Overweight → Overweight $101
2025-12-10 main UBS Buy → Buy $97
2025-12-10 main Barclays Overweight → Overweight $93
2025-12-10 main Mizuho Outperform → Outperform $95
2025-12-10 main Morgan Stanley Overweight → Overweight $93
2025-12-10 main Baird Outperform → Outperform $92
2025-12-05 main Bernstein Market Perform → Market Perform $86
2025-11-13 main Wells Fargo Overweight → Overweight $102
2025-11-03 main TD Cowen Buy → Buy $100
2025-10-30 main Evercore ISI Group Outperform → Outperform $95
2025-10-30 main RBC Capital Outperform → Outperform $93
2025-10-30 main Cantor Fitzgerald Overweight → Overweight $95
2025-10-30 reit Truist Securities Buy → Buy $95
News
RSS: Latest CVS news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-03-19 GALLINA JOHN E Director — 582 $71.86 $41,823
2025-11-20 SANSONE GUY P Director — 1,652 $76.04 $125,618
2025-11-20 AGUIRRE FERNANDO Director — 1,800 $76.04 $136,872
2025-11-20 SHULMAN DOUGLAS H Director — 1,652 $76.04 $125,618
2025-11-20 BALSER JEFFREY R M.D., PH.D. Director — 1,775 $76.04 $134,971
2025-11-20 NORWALK LESLIE V Director — 1,652 $76.04 $125,618
2025-11-20 BROWN C DAVID II Director — 1,775 $76.04 $134,971
2025-11-20 KIRBY JOHN SCOTT Director — 1,652 $76.04 $125,618
2025-11-20 FINUCANE ANNE A Director — 591 $76.04 $44,940
2025-08-20 FINUCANE ANNE A Director — 7,500 $71.02 $532,650
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
402,067.00
+7.85%
372,809.00
+4.20%
357,776.00
+10.95%
322,467.00
Operating Revenue
402,067.00
+7.85%
372,809.00
+4.20%
357,776.00
+10.95%
322,467.00
Cost Of Revenue
346,705.00
+7.87%
321,408.00
+5.95%
303,345.00
+13.20%
267,965.00
Reconciled Cost Of Revenue
346,705.00
+7.87%
321,408.00
+5.95%
303,345.00
+13.20%
267,965.00
Gross Profit
55,362.00
+7.71%
51,401.00
-5.57%
54,431.00
-0.13%
54,502.00
Operating Expense
44,977.00
+7.84%
41,706.00
+4.70%
39,832.00
+4.24%
38,212.00
Other Operating Expenses
44,977.00
+7.84%
41,706.00
+4.70%
39,832.00
+4.24%
38,212.00
Total Expenses
391,682.00
+7.87%
363,114.00
+5.81%
343,177.00
+12.08%
306,177.00
Operating Income
10,385.00
+7.12%
9,695.00
-33.59%
14,599.00
-10.38%
16,290.00
Total Operating Income As Reported
4,660.00
-45.28%
8,516.00
-38.03%
13,743.00
+72.78%
7,954.00
EBITDA
9,861.00
-28.04%
13,703.00
-24.70%
18,197.00
+47.38%
12,347.00
Normalized EBITDA
15,103.00
+4.95%
14,391.00
-24.47%
19,053.00
-7.88%
20,683.00
Reconciled Depreciation
4,606.00
+0.20%
4,597.00
+5.29%
4,366.00
+3.36%
4,224.00
EBIT
5,255.00
-42.29%
9,106.00
-34.16%
13,831.00
+70.27%
8,123.00
Total Unusual Items
-5,242.00
-661.92%
-688.00
+19.63%
-856.00
+89.73%
-8,336.00
Total Unusual Items Excluding Goodwill
-5,242.00
-661.92%
-688.00
+19.63%
-856.00
+89.73%
-8,336.00
Special Income Charges
-5,242.00
-661.92%
-688.00
+19.63%
-856.00
+89.73%
-8,336.00
Other Special Charges
—
-491.00
—
5,803.00
Impairment Of Capital Assets
5,725.00
0.00
0.00
0.00
Restructuring And Mergern Acquisition
0.00
-100.00%
1,179.00
+132.54%
507.00
0.00
Net Income
1,768.00
-61.68%
4,614.00
-44.70%
8,344.00
+93.55%
4,311.00
Pretax Income
2,136.00
-65.26%
6,148.00
-44.97%
11,173.00
+91.45%
5,836.00
Net Non Operating Interest Income Expense
-3,119.00
-5.44%
-2,958.00
-11.29%
-2,658.00
-16.22%
-2,287.00
Interest Expense Non Operating
3,119.00
+5.44%
2,958.00
+11.29%
2,658.00
+16.22%
2,287.00
Net Interest Income
-3,119.00
-5.44%
-2,958.00
-11.29%
-2,658.00
-16.22%
-2,287.00
Interest Expense
3,119.00
+5.44%
2,958.00
+11.29%
2,658.00
+16.22%
2,287.00
Other Income Expense
-5,130.00
-770.97%
-589.00
+23.31%
-768.00
+90.60%
-8,167.00
Other Non Operating Income Expenses
112.00
+13.13%
99.00
+12.50%
88.00
-47.93%
169.00
Gain On Sale Of Business
483.00
0.00
0.00
—
Tax Provision
408.00
-73.88%
1,562.00
-44.31%
2,805.00
+85.88%
1,509.00
Tax Rate For Calcs
0.00
-24.80%
0.00
+1.20%
0.00
-3.09%
0.00
Tax Effect Of Unusual Items
-1,001.22
-472.94%
-174.75
+18.67%
-214.86
+90.05%
-2,159.02
Net Income Including Noncontrolling Interests
1,728.00
-62.32%
4,586.00
-45.20%
8,368.00
+93.39%
4,327.00
Net Income From Continuing Operation Net Minority Interest
1,768.00
-61.68%
4,614.00
-44.70%
8,344.00
+93.55%
4,311.00
Net Income From Continuing And Discontinued Operation
1,768.00
-61.68%
4,614.00
-44.70%
8,344.00
+93.55%
4,311.00
Net Income Continuous Operations
1,728.00
-62.32%
4,586.00
-45.20%
8,368.00
+93.39%
4,327.00
Net Income Discontinuous Operations
—
—
—
0.00
Minority Interests
40.00
+42.86%
28.00
+216.67%
-24.00
-50.00%
-16.00
Normalized Income
6,008.78
+17.19%
5,127.25
-42.94%
8,985.14
-14.33%
10,487.98
Net Income Common Stockholders
1,768.00
-61.68%
4,614.00
-44.70%
8,344.00
+93.55%
4,311.00
Diluted EPS
1.39
-62.02%
3.66
-43.43%
6.47
+98.47%
3.26
Basic EPS
1.40
-61.85%
3.67
-43.45%
6.49
+97.26%
3.29
Basic Average Shares
1,267.00
+0.64%
1,259.00
-2.02%
1,285.00
-2.06%
1,312.00
Diluted Average Shares
1,271.00
+0.71%
1,262.00
-2.17%
1,290.00
-2.49%
1,323.00
Diluted NI Availto Com Stockholders
1,768.00
-61.68%
4,614.00
-44.70%
8,344.00
+93.55%
4,311.00
Gain On Sale Of PPE
0.00
0.00
+100.00%
-349.00
+86.22%
-2,533.00
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
253,538.00
+0.13%
253,215.00
+1.40%
249,728.00
+9.40%
228,275.00
Current Assets
74,714.00
+8.84%
68,645.00
+1.16%
67,858.00
+3.39%
65,633.00
Cash Cash Equivalents And Short Term Investments
10,598.00
-3.59%
10,993.00
-4.03%
11,455.00
-27.14%
15,723.00
Cash And Cash Equivalents
8,453.00
-1.55%
8,586.00
+4.76%
8,196.00
-36.69%
12,945.00
Other Short Term Investments
2,145.00
-10.88%
2,407.00
-26.14%
3,259.00
+17.31%
2,778.00
Receivables
39,779.00
+9.08%
36,469.00
+3.53%
35,227.00
+29.15%
27,276.00
Accounts Receivable
16,316.00
+11.66%
14,612.00
-6.47%
15,622.00
+33.99%
11,659.00
Other Receivables
23,463.00
+7.35%
21,857.00
+11.49%
19,605.00
+25.54%
15,617.00
Inventory
19,246.00
+6.29%
18,107.00
+0.45%
18,025.00
-5.58%
19,090.00
Assets Held For Sale Current
—
—
0.00
-100.00%
908.00
Other Current Assets
5,091.00
+65.51%
3,076.00
-2.38%
3,151.00
+19.54%
2,636.00
Total Non Current Assets
178,824.00
-3.11%
184,570.00
+1.48%
181,870.00
+11.82%
162,642.00
Net PPE
28,056.00
-3.04%
28,937.00
-4.92%
30,435.00
-1.01%
30,745.00
Gross PPE
52,800.00
+0.79%
52,384.00
+2.44%
51,134.00
-2.09%
52,228.00
Accumulated Depreciation
-24,744.00
-5.53%
-23,447.00
-13.28%
-20,699.00
+3.65%
-21,483.00
Properties
0.00
0.00
0.00
0.00
Land And Improvements
1,809.00
-2.06%
1,847.00
-5.67%
1,958.00
-1.90%
1,996.00
Buildings And Improvements
4,593.00
-0.84%
4,632.00
+1.33%
4,571.00
+0.57%
4,545.00
Machinery Furniture Equipment
24,613.00
+5.93%
23,236.00
+11.49%
20,842.00
-4.49%
21,821.00
Other Properties
14,973.00
-6.09%
15,944.00
-7.58%
17,252.00
-2.13%
17,628.00
Leases
6,812.00
+1.29%
6,725.00
+3.29%
6,511.00
+4.38%
6,238.00
Goodwill And Other Intangible Assets
110,986.00
-6.42%
118,595.00
-1.59%
120,506.00
+17.05%
102,953.00
Goodwill
85,478.00
-6.35%
91,272.00
+0.00%
91,272.00
+16.79%
78,150.00
Other Intangible Assets
25,508.00
-6.64%
27,323.00
-6.54%
29,234.00
+17.86%
24,803.00
Investments And Advances
32,669.00
+12.91%
28,934.00
+25.70%
23,019.00
+9.12%
21,096.00
Other Investments
4,572.00
+20.22%
3,803.00
+16.87%
3,254.00
+27.86%
2,545.00
Other Non Current Assets
5,119.00
+6.80%
4,793.00
+2.85%
4,660.00
+0.87%
4,620.00
Total Liabilities Net Minority Interest
178,156.00
+0.38%
177,485.00
+2.54%
173,092.00
+10.60%
156,506.00
Current Liabilities
88,692.00
+4.83%
84,609.00
+6.84%
79,189.00
+14.07%
69,421.00
Payables And Accrued Expenses
81,771.00
+7.69%
75,932.00
+3.54%
73,335.00
+16.13%
63,148.00
Payables
59,384.00
+7.73%
55,122.00
+10.64%
49,820.00
+12.20%
44,403.00
Accounts Payable
17,641.00
+11.01%
15,892.00
+6.68%
14,897.00
+0.40%
14,838.00
Other Payable
41,743.00
+6.41%
39,230.00
+12.33%
34,923.00
+18.12%
29,565.00
Current Accrued Expenses
22,387.00
+7.58%
20,810.00
-11.50%
23,515.00
+25.45%
18,745.00
Employee Benefits
1,994.00
-39.78%
3,311.00
+1.88%
3,250.00
+0.68%
3,228.00
Current Debt And Capital Lease Obligation
5,805.00
-22.54%
7,494.00
+59.01%
4,713.00
+36.37%
3,456.00
Current Debt
4,068.00
-29.17%
5,743.00
+93.24%
2,972.00
+67.15%
1,778.00
Other Current Borrowings
4,068.00
+12.25%
3,624.00
+30.74%
2,772.00
+55.91%
1,778.00
Current Capital Lease Obligation
1,737.00
-0.80%
1,751.00
+0.57%
1,741.00
+3.75%
1,678.00
Other Current Liabilities
1,116.00
-5.66%
1,183.00
+3.68%
1,141.00
-59.50%
2,817.00
Total Non Current Liabilities Net Minority Interest
89,464.00
-3.67%
92,876.00
-1.09%
93,903.00
+7.83%
87,085.00
Long Term Debt And Capital Lease Obligation
74,145.00
-1.70%
75,426.00
+1.01%
74,672.00
+10.99%
67,276.00
Long Term Debt
60,502.00
-0.04%
60,527.00
+3.22%
58,638.00
+16.17%
50,476.00
Long Term Capital Lease Obligation
13,643.00
-8.43%
14,899.00
-7.08%
16,034.00
-4.56%
16,800.00
Defined Pension Benefit
1,994.00
-39.78%
3,311.00
+1.88%
3,250.00
+0.68%
3,228.00
Non Current Pension And Other Postretirement Benefit Plans
1,994.00
-39.78%
3,311.00
+1.88%
3,250.00
+0.68%
3,228.00
Non Current Deferred Liabilities
3,832.00
+0.68%
3,806.00
-11.71%
4,311.00
+7.35%
4,016.00
Non Current Deferred Taxes Liabilities
3,832.00
+0.68%
3,806.00
-11.71%
4,311.00
+7.35%
4,016.00
Other Non Current Liabilities
9,493.00
-8.13%
10,333.00
-11.46%
11,670.00
-7.12%
12,565.00
Stockholders Equity
75,214.00
-0.46%
75,560.00
-1.18%
76,461.00
+6.98%
71,469.00
Common Stock Equity
75,214.00
-0.46%
75,560.00
-1.18%
76,461.00
+6.98%
71,469.00
Capital Stock
50,402.00
+1.49%
49,661.00
+1.37%
48,992.00
+1.66%
48,193.00
Common Stock
50,402.00
+1.49%
49,661.00
+1.37%
48,992.00
+1.66%
48,193.00
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
1,787.00
+0.51%
1,778.00
+0.57%
1,768.00
+0.57%
1,758.00
Ordinary Shares Number
1,271.00
+0.87%
1,260.00
-2.17%
1,288.00
-0.92%
1,300.00
Treasury Shares Number
516.00
-0.39%
518.00
+7.92%
480.00
+4.80%
458.00
Retained Earnings
61,196.00
-2.61%
62,837.00
+2.00%
61,604.00
+9.23%
56,398.00
Gains Losses Not Affecting Retained Earnings
406.00
+438.33%
-120.00
+59.60%
-297.00
+76.50%
-1,264.00
Treasury Stock
36,790.00
-0.08%
36,818.00
+8.81%
33,838.00
+6.22%
31,858.00
Minority Interest
168.00
-1.18%
170.00
-2.86%
175.00
-41.67%
300.00
Other Equity Adjustments
406.00
+438.33%
-120.00
+59.60%
-297.00
+76.50%
-1,264.00
Total Equity Gross Minority Interest
75,382.00
-0.46%
75,730.00
-1.18%
76,636.00
+6.78%
71,769.00
Total Capitalization
135,716.00
-0.27%
136,087.00
+0.73%
135,099.00
+10.79%
121,945.00
Working Capital
-13,978.00
+12.44%
-15,964.00
-40.89%
-11,331.00
-199.13%
-3,788.00
Invested Capital
139,784.00
-1.44%
141,830.00
+2.72%
138,071.00
+11.60%
123,723.00
Total Debt
79,950.00
-3.58%
82,920.00
+4.45%
79,385.00
+12.23%
70,732.00
Net Debt
56,117.00
-2.72%
57,684.00
+7.99%
53,414.00
+35.88%
39,309.00
Capital Lease Obligations
15,380.00
-7.63%
16,650.00
-6.33%
17,775.00
-3.80%
18,478.00
Net Tangible Assets
-35,772.00
+16.88%
-43,035.00
+2.29%
-44,045.00
-39.90%
-31,484.00
Tangible Book Value
-35,772.00
+16.88%
-43,035.00
+2.29%
-44,045.00
-39.90%
-31,484.00
Available For Sale Securities
26,721.00
+12.38%
23,777.00
+27.96%
18,582.00
+5.81%
17,562.00
Commercial Paper
0.00
-100.00%
2,119.00
+959.50%
200.00
0.00
Held To Maturity Securities
1,376.00
+1.62%
1,354.00
+14.45%
1,183.00
+19.62%
989.00
Inventories Adjustments Allowances
—
—
-607.00
-8.59%
-559.00
Investmentin Financial Assets
28,097.00
+11.80%
25,131.00
+27.15%
19,765.00
+6.54%
18,551.00
Other Inventories
—
—
18,632.00
-5.18%
19,649.00
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
10,639.00
+16.82%
9,107.00
-32.17%
13,426.00
-17.01%
16,177.00
Cash Flow From Continuing Operating Activities
10,639.00
+16.82%
9,107.00
-32.17%
13,426.00
-17.01%
16,177.00
Net Income From Continuing Operations
1,728.00
-62.32%
4,586.00
-45.20%
8,368.00
+93.39%
4,327.00
Depreciation Amortization Depletion
4,606.00
+0.20%
4,597.00
+5.29%
4,366.00
+3.36%
4,224.00
Depreciation And Amortization
4,606.00
+0.20%
4,597.00
+5.29%
4,366.00
+3.36%
4,224.00
Other Non Cash Items
-336.00
+33.07%
-502.00
-290.15%
264.00
-20.48%
332.00
Stock Based Compensation
535.00
-0.93%
540.00
-8.16%
588.00
+31.54%
447.00
Asset Impairment Charge
5,725.00
+581.55%
840.00
+452.63%
152.00
0.00
Deferred Tax
102.00
+117.83%
-572.00
+15.38%
-676.00
+66.68%
-2,029.00
Deferred Income Tax
102.00
+117.83%
-572.00
+15.38%
-676.00
+66.68%
-2,029.00
Operating Gains Losses
-247.00
+49.69%
-491.00
-240.69%
349.00
-83.04%
2,058.00
Change In Working Capital
-1,474.00
-1452.29%
109.00
+626.67%
15.00
-99.78%
6,818.00
Change In Receivables
-3,498.00
-168.87%
-1,301.00
+79.22%
-6,260.00
-110.70%
-2,971.00
Changes In Account Receivables
-3,498.00
-168.87%
-1,301.00
+79.22%
-6,260.00
-110.70%
-2,971.00
Change In Inventory
-1,267.00
-1142.16%
-102.00
-108.27%
1,233.00
+185.92%
-1,435.00
Change In Payables And Accrued Expense
3,871.00
-23.98%
5,092.00
+26.92%
4,012.00
-23.61%
5,252.00
Change In Payable
3,871.00
-23.98%
5,092.00
+26.92%
4,012.00
-23.61%
5,252.00
Change In Account Payable
3,855.00
+65.10%
2,335.00
-35.46%
3,618.00
-15.07%
4,260.00
Change In Other Current Assets
-2,593.00
-6723.68%
-38.00
+92.55%
-510.00
-3.87%
-491.00
Change In Other Current Liabilities
2,013.00
+156.83%
-3,542.00
-330.00%
1,540.00
-76.17%
6,463.00
Investing Cash Flow
-5,871.00
+22.88%
-7,613.00
+63.55%
-20,889.00
-313.89%
-5,047.00
Cash Flow From Continuing Investing Activities
-5,871.00
+22.88%
-7,613.00
+63.55%
-20,889.00
-313.89%
-5,047.00
Net PPE Purchase And Sale
-2,832.00
-1.83%
-2,781.00
+8.25%
-3,031.00
-11.15%
-2,727.00
Purchase Of PPE
-2,832.00
-1.83%
-2,781.00
+8.25%
-3,031.00
-11.15%
-2,727.00
Sale Of PPE
—
—
—
0.00
Capital Expenditure
-2,832.00
-1.83%
-2,781.00
+8.25%
-3,031.00
-11.15%
-2,727.00
Net Investment Purchase And Sale
-2,629.00
+45.66%
-4,838.00
-268.19%
-1,314.00
-29.20%
-1,017.00
Purchase Of Investment
-15,012.00
+1.18%
-15,191.00
-67.99%
-9,043.00
-16.74%
-7,746.00
Sale Of Investment
12,383.00
+19.61%
10,353.00
+33.95%
7,729.00
+14.86%
6,729.00
Net Business Purchase And Sale
-436.00
-358.95%
-95.00
+99.43%
-16,612.00
-1096.83%
-1,388.00
Purchase Of Business
-436.00
-358.95%
-95.00
+99.43%
-16,612.00
-1096.83%
-1,388.00
Gain Loss On Sale Of Business
-247.00
0.00
0.00
+100.00%
-475.00
Net Other Investing Changes
26.00
-74.26%
101.00
+48.53%
68.00
-20.00%
85.00
Financing Cash Flow
-4,940.00
-335.24%
-1,135.00
-142.30%
2,683.00
+125.51%
-10,516.00
Cash Flow From Continuing Financing Activities
-4,940.00
-335.24%
-1,135.00
-142.30%
2,683.00
+125.51%
-10,516.00
Net Issuance Payments Of Debt
-1,779.00
-135.17%
5,059.00
-36.22%
7,932.00
+288.36%
-4,211.00
Issuance Of Debt
3,969.00
-59.63%
9,832.00
-38.92%
16,098.00
0.00
Repayment Of Debt
-5,748.00
-20.43%
-4,773.00
+41.55%
-8,166.00
-93.92%
-4,211.00
Long Term Debt Issuance
3,969.00
-49.84%
7,913.00
-27.39%
10,898.00
0.00
Long Term Debt Payments
-3,629.00
+23.97%
-4,773.00
-50.76%
-3,166.00
+24.82%
-4,211.00
Net Long Term Debt Issuance
340.00
-89.17%
3,140.00
-59.39%
7,732.00
+283.61%
-4,211.00
Short Term Debt Issuance
0.00
-100.00%
1,919.00
-63.10%
5,200.00
0.00
Short Term Debt Payments
-2,119.00
0.00
+100.00%
-5,000.00
0.00
Net Short Term Debt Issuance
-2,119.00
-210.42%
1,919.00
+859.50%
200.00
0.00
Net Common Stock Issuance
0.00
+100.00%
-3,023.00
-50.25%
-2,012.00
+42.51%
-3,500.00
Common Stock Payments
0.00
+100.00%
-3,023.00
-50.25%
-2,012.00
+42.51%
-3,500.00
Common Stock Dividend Paid
-3,397.00
-0.71%
-3,373.00
-7.69%
-3,132.00
-7.74%
-2,907.00
Cash Dividends Paid
-3,397.00
-0.71%
-3,373.00
-7.69%
-3,132.00
-7.74%
-2,907.00
Repurchase Of Capital Stock
0.00
+100.00%
-3,023.00
-50.25%
-2,012.00
+42.51%
-3,500.00
Proceeds From Stock Option Exercised
394.00
+9.14%
361.00
+30.32%
277.00
-49.73%
551.00
Net Other Financing Charges
-158.00
+0.63%
-159.00
+58.38%
-382.00
+14.92%
-449.00
Changes In Cash
-172.00
-147.91%
359.00
+107.51%
-4,780.00
-878.50%
614.00
Beginning Cash Position
8,884.00
+4.21%
8,525.00
-35.93%
13,305.00
+4.84%
12,691.00
End Cash Position
8,712.00
-1.94%
8,884.00
+4.21%
8,525.00
-35.93%
13,305.00
Free Cash Flow
7,807.00
+23.41%
6,326.00
-39.14%
10,395.00
-22.71%
13,450.00
Sale Of Business
—
0.00
0.00
—
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category